Clopidogrel Bisulfate Intermediate (2-(2-Chlorophenyl)glycine) (CAS NO : 141196-64-7)

2-(2-Chlorophenyl)glycine (CAS 141196-64-7) acts as a pivotal chiral building block in the high purity fine chemicals sector, where American CDMOs increasingly prioritize its use in the asymmetric synthesis of Clopidogrel and related thienopyridine-class antiplatelet agents. DL-2-Amino-2-(2-chlorophenyl)acetic acid has emerged as a high-demand specialty compound for bulk chemical supplier networks in the United States, driven by a strategic emphasis on domestic supply chain security and the necessity for rigorous USP-grade analytical standards that align with FDA regulatory frameworks. H-DL-Phg(2-Cl)-OH remains an indispensable component for custom synthesis services, providing a high-performance platform for the development of next-generation cardiovascular therapies where maintaining exacting enantiomeric profiles through HPLC and NMR is critical for ensuring bioequivalence in complex pharmaceutical formulations. We are an established Clopidogrel Bisulfate Intermediate (2-(2-Chlorophenyl)glycine) intermediates supplier with Clopidogrel Bisulfate Intermediate (2-(2-Chlorophenyl)glycine) >= 99% purity in the american region, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting Clopidogrel Bisulfate Intermediate (2-(2-Chlorophenyl)glycine) COA/TDS/SDS region-specific regulatory support, reliable lead times, united states nationwide supply chain capabilities